Provided by Tiger Trade Technology Pte. Ltd.

CHANGMAO BIO

0.210
-0.003-1.41%
Volume:36.00K
Turnover:7K
Market Cap:111.24M
PE:-1.67
High:0.201
Open:0.201
Low:0.190
Close:0.213
52wk High:0.360
52wk Low:0.190
Shares:529.70M
HK Float Shares:183.70M
Volume Ratio:0.62
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.126
ROE:-8.66%
ROA:-0.48%
PB:0.19
PE(LYR):-1.67
PS:0.17

Loading ...

CHANGMAO BIO Secures RMB93.00 Million Ten-Year Syndicated Loan to Refinance Existing Project Debt

Bulletin Express
·
Nov 09

Changmao Biochemical Engineering - Co and Banks Entered into New Loan Agreement to Replace Outstanding Balance of RMB93 Mln

THOMSON REUTERS
·
Nov 09

Changmao Biochemical Refinances RMB 93 Million Project Loan with 10-Year Bank Loan

Reuters
·
Nov 09

Changmao Biochemical Engineering Insider Purchases Yet To Pay Off Regardless Of Recent Strength

Simply Wall St.
·
Oct 09

Changmao Biochemical FY26 H1 Net Loss Narrows to RMB 5.09 Million; Revenue Rises 6.3% to RMB 289.55 Million

Reuters
·
Sep 01

常茂生物(00954.HK)2026年中期业绩:营收增长6.3% 亏损同比收窄逾八成 仍存偿债与持续经营不确定性

Bulletin Express
·
Aug 18

Changmao Biochemical FY26 H1 Net Loss Narrows 80.88% to RMB 4.93 Million; Revenue Rises 6.34% to RMB 289.55 Million

Reuters
·
Aug 18

Changmao Bio projects H1 2026 net loss to narrow to RMB4–6 million, vs. RMB25.79 million a year earlier

Bulletin Express
·
Aug 03

Changmao Biochemical Expects H1 Net Loss Narrows to RMB 4 Million-RMB 6 Million

Reuters
·
Aug 03

Changmao Biochemical Engineering - Expected Hy Results Due to Optimized Product Structure, Others Driving Revenue and Gross Profit Growth

THOMSON REUTERS
·
Aug 03

Changmao Biochemical Engineering Co - Expects Net Loss of RMB4 Mln-RMB6 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 03

Changmao Bio Schedules 18 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Dividend Proposal

Bulletin Express
·
Aug 03

Changmao Biochemical Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 03

Changmao Biochemical: July 2026 Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express
·
Aug 03

CHANGMAO BIO Maintains Stable Share Structure in June; Public Float Remains Compliant

Bulletin Express
·
Jul 02

Changmao Bio Releases Updated Articles of Association, Clarifies Capital Structure and Governance Framework

Bulletin Express
·
Jun 09

CHANGMAO BIO AGM: 100% Shareholder Support Secures 2026 Mandates, Audited 2025 Results Approved

Bulletin Express
·
May 28

Changmao Biochemical Engineering held annual shareholder meeting

Reuters
·
May 28